DK
Dhirendra Kumar Tiwari
About Dhirendra Kumar Tiwari
Data last updated:
Dhirendra Kumar Tiwari is a Director at Tiwari Pharma Private Limited (since 2018), Director at Uhl Pharma Private Limited (since 2024) and Director at Tradewinds Overseas Private Limited (since 2023), and holds 1 more current directorship. The companies operate in Pharma. The largest current company by reported revenue is Tiwari Pharma Private Limited at ₹561 Cr (FY 2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Tiwari Pharma Private Limited U24304HP2018PTC007271 | Director | 17 Dec 2018 | 2018 | ₹561 Cr (FY 2024) | Active |
| Uhl Pharma Private Limited U47721DL2024PTC432575 | Director | 11 Jun 2024 | 2024 | Active | |
| Tradewinds Overseas Private Limited U47721GJ2023PTC143142 | Director | 20 Jul 2023 | 2023 | Active | |
| Sucantis Biotech Private Limited U24299HR2021PTC099275 | Director | 09 Jun 2022 | 2021 | Active |
Board colleagues of Dhirendra Kumar Tiwari
| Name | DIN | Company | Designation |
|---|---|---|---|
| Ajay Kumar Tiwari | 08306335 | Tiwari Pharma Private Limited | Director |
| Dilip Kumar Tiwari | 08306334 | Tiwari Pharma Private Limited , Sucantis Biotech Private Limited | Director |
| Dharminder Bhatia Singh | 00037234 | Uhl Pharma Private Limited | Director |
| Dipeshbhai Harshdbhai Parikh | 07579854 | Tradewinds Overseas Private Limited | Non- Individual Subscriber |
| Raj Mansukhbhai Sanghavi | 10248163 | Tradewinds Overseas Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Dhirendra Kumar Tiwari
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Dhirendra Kumar Tiwari
Dhirendra Kumar Tiwari currently holds 4 directorships: Tiwari Pharma Private Limited (Director, since 17 Dec 2018, revenue ₹561 Cr (FY 2024)); Uhl Pharma Private Limited (Director, since 11 Jun 2024); Tradewinds Overseas Private Limited (Director, since 20 Jul 2023); Sucantis Biotech Private Limited (Director, since 09 Jun 2022).
Dhirendra Kumar Tiwari was first appointed on 17 Dec 2018 as Director at Tiwari Pharma Private Limited. The most recent appointment on record is 11 Jun 2024 at Uhl Pharma Private Limited.
The current boards of Dhirendra Kumar Tiwari's companies include Ajay Kumar Tiwari (Tiwari Pharma Private Limited), Dilip Kumar Tiwari (Tiwari Pharma Private Limited), Dharminder Bhatia Singh (Uhl Pharma Private Limited), Dipeshbhai Harshdbhai Parikh (Tradewinds Overseas Private Limited), Raj Mansukhbhai Sanghavi (Tradewinds Overseas Private Limited).